Anti-SUN3 monoclonal antibody

Pre-made anti-SUN3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SUN3/SUN3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1856-Ab-1/ GM-Tg-hg-IP1856-Ab-2Anti-Human SUN3 monoclonal antibodyHuman
GM-Tg-rg-IP1856-Ab-1/ GM-Tg-rg-IP1856-Ab-2Anti-Rat SUN3 monoclonal antibodyRat
GM-Tg-mg-IP1856-Ab-1/ GM-Tg-mg-IP1856-Ab-2Anti-Mouse SUN3 monoclonal antibodyMouse
GM-Tg-cynog-IP1856-Ab-1/ GM-Tg-cynog-IP1856-Ab-2Anti-Cynomolgus/ Rhesus macaque SUN3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1856-Ab-1/ GM-Tg-felg-IP1856-Ab-2Anti-Feline SUN3 monoclonal antibodyFeline
GM-Tg-cang-IP1856-Ab-1/ GM-Tg-cang-IP1856-Ab-2Anti-Canine SUN3 monoclonal antibodyCanine
GM-Tg-bovg-IP1856-Ab-1/ GM-Tg-bovg-IP1856-Ab-2Anti-Bovine SUN3 monoclonal antibodyBovine
GM-Tg-equg-IP1856-Ab-1/ GM-Tg-equg-IP1856-Ab-2Anti-Equine SUN3 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1856-Ab-1/ GM-Tg-hg-IP1856-Ab-2; GM-Tg-rg-IP1856-Ab-1/ GM-Tg-rg-IP1856-Ab-2;
GM-Tg-mg-IP1856-Ab-1/ GM-Tg-mg-IP1856-Ab-2; GM-Tg-cynog-IP1856-Ab-1/ GM-Tg-cynog-IP1856-Ab-2;
GM-Tg-felg-IP1856-Ab-1/ GM-Tg-felg-IP1856-Ab-2; GM-Tg-cang-IP1856-Ab-1/ GM-Tg-cang-IP1856-Ab-2;
GM-Tg-bovg-IP1856-Ab-1/ GM-Tg-bovg-IP1856-Ab-2; GM-Tg-equg-IP1856-Ab-1/ GM-Tg-equg-IP1856-Ab-2
Products NameAnti-SUN3 monoclonal antibody
Formatmab
Target NameSUN3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SUN3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1856-Ag-1Recombinant multi-species SUN3/ SUNC1 protein


    Target information

    Target IDGM-IP1856
    Target NameSUN3
    Gene ID256979,194974,498412,695546,480765,101081714,537130,100066102
    Gene Symbol and SynonymsSUN3,SUNC1
    Uniprot AccessionQ8TAQ9,Q0II64
    Uniprot Entry NameSUN3_HUMAN,SUN3_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000164744
    Target ClassificationN/A

    The target: SUN3, gene name: SUN3, also named as SUNC1. Predicted to enable protein-membrane adaptor activity. Predicted to be involved in nuclear envelope organization. Predicted to be integral component of nuclear inner membrane. Predicted to be part of meiotic nuclear membrane microtubule tethering complex. Predicted to be active in nuclear envelope. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.